"Understanding the Molecular Pathogenesis of Phenotypes using Gene Co-Expression Network-Based Models."

Dr. Stevens received his PhD in Pharmacology from the University of Minnesota in 1980 and was awarded a PRAT Fellowship from the National Institute of General Medical Sciences at the National Institutes of Health in Bethesda, MD. He was appointed a Senior Staff Fellow in the Bureau of Biologics, FDA in 1983, and in 1986 joined the W. Alton Jones Cell Science Center, Lake Placid, NY, as a Senior Scientist. He was appointed Executive Director of the Center in 1992, serving in that capacity until 1998 when he became a Professor of Pathology at the University of Vermont. He joined Lilly Research Laboratory in 2000. Dr. Stevens has also served in a number of profession capacities. He was a member of the Board of Directors for Upstate Biotechnology and the Interim Vice President for Research and Development for Argonex Pharmaceuticals. He has also served the Society of Toxicology as President of both the Molecular Biology and Mechanisms Specialty Sections. Dr. Stevens has organized numerous sessions at national meetings, including SOT plenary sessions, and chaired a number of meetings including the Gordon Research Conferences, and is a member of the HESI Board of Trustees. He received the Achievement Award from the Society of Toxicology in 1994 and was elected a Fellow of the American Association for the Advancement of Sciences in 1996. Dr. Stevens research interests are in the areas of predictive and molecular/investigative toxicology and adverse drug reactions. He has studied the role of gene expression in mechanisms of cell injury for over 2 decades and was among the first to adopt gene expression analysis to understand mechanisms of toxicity. He has published over 90 peer reviewed articles.

Contact

  Margaret Weber
  maw71@psu.edu
  814-865-7697